Genky DrugStores Co., Ltd. provided earning guidance for the fiscal year ending June 30, 2022. For the period, the company expects net sales of JPY 160,000 million, operating income of JPY 6,500 million, ordinary income of JPY 6,800 million, net income attributable to owners of parent JPY 4,720 million and net income per share JPY 310.99.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,650 JPY | -2.25% | -2.08% | +3.66% |
Apr. 30 | Genky Drugstores Co., Ltd. Reports Sales Results for the Month and Third Quarter Ended April 2024 | CI |
Apr. 25 | Genky Drugstores Co., Ltd. Provides Dividend Guidance for the Fiscal Year 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.66% | 567M | |
-31.48% | 15.43B | |
-22.25% | 12.31B | |
-25.47% | 6.59B | |
+12.51% | 6.3B | |
-9.71% | 5.88B | |
-0.15% | 4.74B | |
+60.03% | 4.7B | |
-4.98% | 4.03B | |
-8.76% | 3.58B |
- Stock Market
- Equities
- 9267 Stock
- News Genky DrugStores Co., Ltd.
- Genky Drugstores Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2022